Researchers discover how mutations disrupt protein splicing and cause disease

An international research team has uncovered a new mechanism crucial to the production of cellular proteins.

Medartis increases sales by 21% (CER) and improves its underlying EBITDA margin to 16% – Biotech Investments

Medartis Holding AG / Key word(s): Annual Results 12-March-2024 / 06:30 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer

March 13, 2024

Expectation vs. Reality: Improving the Patient Payment Experience

Ryne Natzke, Chief Revenue Officer, TrustCommerce, a Sphere Company If you’ve ever worked behind the scenes at a provider organization, you likely gained a deep

October 7, 2023

Late Tenecteplase Not Beneficial for Stroke Patients With LVOs

PHOENIX — Selected stroke patients did not benefit clinically from having the window of tenecteplase therapy extended beyond the first few hours of stroke onset,

February 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.